Hospira is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™ by developing, manufacturing and marketing products that help improve the productivity, safety and efficacy of patient care. In February 2007, Hospira acquired Mayne Pharma Limited to become the world leader in specialty generic injectable pharmaceuticals.
With 70 years of service to the hospital industry, Hospira's portfolio includes one of the industry's broadest lines of generic acute-care and oncology injectables, and integrated solutions for medication management and infusion therapy. Hospira is also a leading provider of contract manufacturing services to proprietary pharmaceutical and biotechnology companies for formulation development, filling and finishing of injectable pharmaceuticals. Its broad portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.
Through its offering of high-quality, lower-cost alternatives to proprietary medications, Hospira continues to help reduce the overall costs of healthcare — to improve both the affordability of care for patients and the financial strength of the global healthcare system. The company also is a pioneer in providing innovative solutions to improve patient and healthcare worker safety.
Hospira UK is an integral part of Hospira's global operations and is the Head office for the Europe, Middle East and Africa region. The UK is one of the largest operations for Hospira in Europe. In addition to our critical care products, the UK has been at the forefront in launching generic oncology products into the market place and today has one of the widest ranges available. Considerable attention had been paid to the clear labelling and packaging of all medicines with the aim of improving patient safety.
Hospira has a well-established range of intravenous (I.V.) devices. GemStar® infusion system, Plum A® infusion system, Abbocath® - T catheters, Butterfly® infusion sets, Receptal® waste disposal system and Transpac® disposable pressure transducers are familiar products in the portfolio.
By working with its customers to integrate technologies at the point of care, Hospira is the partner of choice for improving patient and workplace safety, clinical outcomes and cost management, and caregiver efficiency and effectiveness.
The name "Hospira", selected by the company's employees before its launch as an independent company in 2004, is derived from the words hospital, spirit, inspire and the Latin word spero, which means hope. It reflects the company's primary market focus and its heritage as the core global hospital products business of Abbott Laboratories, and expresses the hope and optimism that are critical in the healthcare industry.
Hospira had 2006 sales of approximately $2.7 billion and is headquartered north of Chicago in Lake Forest, Ill.
Learn more: